Experience

Davis Polk advised the underwriters in connection with the offering of C$500 million aggregate principal amount of 1.650% Canadian dollar bonds due 2024 issued by Export Development Canada…

Davis Polk advised the underwriters in connection with the debut SEC-registered notes offering by Las Vegas Sands Corp. of $1.75 billion of its 3.200% senior notes due 2024, $1 billion…

Davis Polk advised the joint book-running managers in connection with the $350 million SEC-registered follow-on offering of 100,000,000 shares of common stock of Clear Channel Outdoor…

Davis Polk advised the respective agents of the Brazilian underwriters in connection with the follow-on offering by Petróleo Brasileiro S.A. — Petrobras of 393,187,500 common shares of BR…

Davis Polk advised the initial purchasers in connection with a $300 million Regulation S high-yield offering by KWG Group Holding Limited of its 7.40% senior notes due 2024. KWG Group…

Davis Polk advised Oryzon Genomics, S.A. on its €20 million private placement of its ordinary shares pursuant to a capital increase. The offering consisted of a private placement to…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $110 million initial public offering of 7,857,145 shares of common stock by…

Davis Polk is acting as special tax counsel to Pfizer Inc. on the combination of its off-patent branded and generic established medicines business, Upjohn, with Mylan N.V. Under the terms…

Davis Polk is advising an ad hoc group of prepetition term loan lenders and initial debtor-in-possession financing lenders in the chapter 11 restructuring of Philadelphia Energy Solutions…

Davis Polk advised the administrative agent and certain revolving lenders under Crossmark Holdings, Inc.’s first-lien credit agreement in connection with the out-of-court restructuring of…